---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-004833"
form_type: "8-K"
ticker: "MCRB"
cik: "0001609809"
company_name: "Seres Therapeutics, Inc."
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:30:55.266308+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Seres Therapeutics posts updated corporate presentation; no specific new financial or operational data disclosed

## Summary
- Company filed an 8-K on Jan 9, 2024 to disclose an updated corporate presentation.
- Presentation posted on Seres' investor relations website; no financial results or guidance provided.
- Exhibit 99.1 text truncated; full presentation content not available for review.
- Filing is a routine Regulation FD disclosure with no material new information.

## SEC filing metadata
- accession: 0001193125-24-004833
- form_type: 8-K
- ticker: MCRB
- cik: 0001609809
- company_name: Seres Therapeutics, Inc.
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609809/000119312524004833/0001193125-24-004833-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609809/000119312524004833/d90190d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-004833
- JSON: https://secwatch.observer/filing/0001193125-24-004833.json
- Plain text: https://secwatch.observer/filing/0001193125-24-004833.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.